CAC
ROIVW

Cowen and Company’s Roivant Sciences Ltd. Warrant ROIVW Stock Holding History

Cowen and Company’s Portfolio ROIVW Stock Details ROIVW Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2023
Q1 		– Sell
-62,100
Closed -$120K – 743
2022
Q4 		$120K Buy
62,100
+37,537
+153% +$41.1K 0.01% 201
2022
Q3 		$10K Buy
+24,563
New +$13.1K ﹤0.01% 430

Other funds holding ROIVW

LP
LMR Partners London, United Kingdom $45.4B AUM 60.47% 1-Year Est. Return
MF
Magnetar Financial Evanston, Illinois $9.84B AUM 190.63% 1-Year Est. Return
D.E. Shaw & Co
D.E. Shaw & Co New York $166B AUM 43.98% 1-Year Est. Return
DM
Deerfield Management New York $8.48B AUM 99.04% 1-Year Est. Return
TSC
Two Seas Capital Rye, New York $7.15B AUM 169.27% 1-Year Est. Return
CL
CSS LLC Chicago, Illinois $2.09B AUM 58.96% 1-Year Est. Return
AC
Aristeia Capital Greenwich, Connecticut $4.82B AUM 24.91% 1-Year Est. Return
PFM
Privium Fund Management Amsterdam, Netherlands $480M AUM 77.45% 1-Year Est. Return
SOA
Sea Otter Advisors Miami, Florida $1.78M AUM 2.28% 1-Year Est. Return
Walleye Capital
Walleye Capital New York $28B AUM 44.22% 1-Year Est. Return

Cowen and Company's ROIVW Position: Q1 2023 in Review

Cowen and Company sold out of Roivant Sciences Ltd. Warrant (ROIVW) in Q1 2023, closing a stake of 62,100 shares — an estimated $120K sold.

Cowen and Company first reported a position in ROIVW in Q3 2022 and held it in 2 quarters. The position peaked at $120K in Q4 2022. 23 funds tracked by Wall St. Rank hold ROIVW as of Q1 2023.

  • Cowen and Company reported no remaining Roivant Sciences Ltd. Warrant position as of Q1 2023 after selling out during the quarter.
  • Cowen and Company sold 62,100 Roivant Sciences Ltd. Warrant shares in Q1 2023, an estimated $120K.
  • Cowen and Company first reported a position in Roivant Sciences Ltd. Warrant in Q3 2022 and held it in 2 quarters.
  • Cowen and Company's Roivant Sciences Ltd. Warrant position peaked at $120K in Q4 2022.
  • 23 funds tracked by Wall St. Rank held Roivant Sciences Ltd. Warrant as of Q1 2023.

Based on Cowen and Company's 13F filing for Q1 2023, filed 9 May 2023.